Lung cancer, long known to affect smokers, is seeing a significant rise in people who do not smoke, said doctors, raising ...
Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...
On December 27, 2024, subcutaneous nivolumab (Opdivo Qvantig) was approved by the FDA in all previously approved adult solid ...
HMBD-001 is under clinical development by Hummingbird Bioscience and currently in Phase I for Pancreatic Ductal Adenocarcinoma.
for NRG1 gene fusion-positive pancreatic adenocarcinoma and non-small cell lung cancer (NSCLC) on Wednesday. The approval stipulates use in advanced, unresectable, or metastatic disease that ...
The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...
unresectable or metastatic non-small cell lung cancer (NSCLC) or pancreatic adenocarcinoma (PDAC) harboring a neuregulin 1 (NRG1) gene fusion with disease progression on or after prior systemic ...